Lakefront Biotherapeutics (LKFT) Shares Outstanding (2017 - 2025)

Lakefront Biotherapeutics (LKFT) has 9 years of Shares Outstanding data on file, last reported at $76.7 million in Q4 2025.

• Shares Outstanding for Q4 2025 came in at $76.7 million, up 8.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $76.7 million (up 8.93% YoY), and the FY2025 annual result was $76.7 million, up 8.93% from the prior year.
• Shares Outstanding advanced to $76.7 million in Q4 2025 per LKFT's latest filing, from $70.4 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $76.7 million in Q4 2025 and troughed at $67.2 million in Q4 2022.
• A 5-year average of $72.0 million and a median of $70.9 million in 2023 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding dropped 10.43% in 2022, then climbed 8.93% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $75.0 million in 2021, then decreased by 10.43% to $67.2 million in 2022, then grew by 5.56% to $70.9 million in 2023, then declined by 0.68% to $70.4 million in 2024, then rose by 8.93% to $76.7 million in 2025.
• Business Quant data shows LKFT's Shares Outstanding at $76.7 million in Q4 2025, $70.4 million in Q4 2024, and $70.9 million in Q4 2023.